Publications by authors named "Lydia Akello"

Claim this Profile
P
Predicted choice and acceptability of regimens for tuberculosis preventive treatment among people living with HIV in Uganda - a discrete choice experiment.
Hélène E Aschmann, Allan Musinguzi, Jillian L Kadota, Catherine Namale, Juliet Kakeeto, Lydia Akello

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment.
Hélène E Aschmann, Allan Musinguzi, Jillian L Kadota, Catherine Namale, Juliet Kakeeto, Lydia Akello

J Int AIDS Soc· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda.
Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann, Lydia Akello, Fred Welishe

Open Forum Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
Allan Musinguzi, Joan R Kasidi, Jillian L Kadota, Fred Welishe, Anne Nakitende, Lydia Akello

PLOS Glob Public Health· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda.
Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann, Lydia Akello, Fred Welishe

medRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
Allan Musinguzi, Joan R Kasidi, Jillian L Kadota, Fred Welishe, Anne Nakitende, Lydia Akello

medRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
Fred C Semitala, Jillian L Kadota, Allan Musinguzi, Fred Welishe, Anne Nakitende, Lydia Akello

PLoS Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences of people living with HIV for features of tuberculosis preventive treatment regimens - a discrete choice experiment.
Hélène E Aschmann, Allan Musinguzi, Jillian L Kadota, Catherine Namale, Juliet Kakeeto, Lydia Akello

medRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
Fred C Semitala, Jillian L Kadota, Allan Musinguzi, Juliet Nabunje, Fred Welishe, Lydia Akello

PLoS Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis